← FDA Drug Approvals (Drugs@FDA)

ETOMIDATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2016-02-25

Drug application

FDA Application #
ANDA202354
Application type
Abbreviated New Drug Application (Generic)
Brand name
ETOMIDATE
Generic name
ETOMIDATE
Active ingredients
ETOMIDATE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
HIKMA
Manufacturer
Hikma Pharmaceuticals USA Inc.
First approval
2016-02-25

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown